Showing results (1-10 of 279) with videos related to
Sort By:
Pageof 28
Therapeutic Advances in Hematology|April 23, 2013
Next-generation sequencing in hematologic malignancies: what will be the dividends?Jason D Merker, Anton Valouev, Jason GotlibThe Journal of Molecular Diagnostics : JMD|December 5, 2009
Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratoryJason D Merker, Carol D Jones, Stephen T Oh, et al.Blood|January 10, 2009
Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification systemOlga K Weinberg, Mahesh Seetharam, Li Ren, et al.Current Hematology Reports|December 22, 2004
Farnesyltransferase inhibitor therapy in acute myelogenous leukemiaJason GotlibCurrent Hematologic Malignancy Reports|September 26, 2015
Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic MastocytosisJason GotlibAmerican Journal of Hematology|October 22, 2015
World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and managementJason GotlibActa Haematologica|July 5, 2005
Molecular classification and pathogenesis of eosinophilic disorders: 2005 updateJason GotlibHematology. American Society of Hematology. Education Program|December 9, 2022
Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasmsJason GotlibHematology. American Society of Hematology. Education Program|December 10, 2013
JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedsideJason GotlibCurrent Opinion in Hematology|January 15, 2010
Eosinophilic myeloid disorders: new classification and novel therapeutic strategiesJason GotlibPageof 28